Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preladenant for Neuroleptic Induced Akathisia
NCT00693472Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Aug 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of preladenant in akathisia, sponsored by Merck & Co.. Started Aug 2007; status: terminated.
02
Drugs
preladenant
03
Conditions
akathisia
Beyond the preview
Go deeper on NCT00693472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693472.